Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of EUR 99.49 million. The enterprise value is 46.39 million.

Market Cap	99.49M
Enterprise Value	46.39M

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.09 million shares outstanding. The number of shares has increased by 58.85% in one year.

Current Share Class	n/a
Shares Outstanding	72.09M
Shares Change (YoY)	+58.85%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	2.21%
Owned by Institutions (%)	17.08%
Float	39.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.09
PB Ratio	0.79
P/TBV Ratio	0.79
P/FCF Ratio	5.05
P/OCF Ratio	4.48
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.31
EV / Sales	0.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2.35

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.67.

Current Ratio	1.73
Quick Ratio	1.00
Debt / Equity	0.67
Debt / EBITDA	n/a
Debt / FCF	4.33
Interest Coverage	-7.99

Financial Efficiency

Return on equity (ROE) is -34.08% and return on invested capital (ROIC) is -19.21%.

Return on Equity (ROE)	-34.08%
Return on Assets (ROA)	-10.37%
Return on Invested Capital (ROIC)	-19.21%
Return on Capital Employed (ROCE)	-27.41%
Revenue Per Employee	217,072
Profits Per Employee	-162,134
Employee Count	222
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.50% in the last 52 weeks. The beta is 3.38, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.38
52-Week Price Change	-42.50%
50-Day Moving Average	1.31
200-Day Moving Average	1.68
Relative Strength Index (RSI)	56.41
Average Volume (20 Days)	175,246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of EUR 47.54 million and -35.51 million in losses. Loss per share was -0.40.

Revenue	47.54M
Gross Profit	47.54M
Operating Income	-57.52M
Pretax Income	-35.51M
Net Income	-35.51M
EBITDA	-46.61M
EBIT	-57.52M
Loss Per Share	-0.40

Full Income Statement

Balance Sheet

The company has 138.37 million in cash and 85.26 million in debt, giving a net cash position of 53.10 million or 0.74 per share.

Cash & Cash Equivalents	138.37M
Total Debt	85.26M
Net Cash	53.10M
Net Cash Per Share	0.74
Equity (Book Value)	126.56M
Book Value Per Share	1.76
Working Capital	116.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 22.21 million and capital expenditures -2.49 million, giving a free cash flow of 19.71 million.

Operating Cash Flow	22.21M
Capital Expenditures	-2.49M
Free Cash Flow	19.71M
FCF Per Share	0.27

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -121.00% and -74.69%.

Gross Margin	100.00%
Operating Margin	-121.00%
Pretax Margin	-74.69%
Profit Margin	-74.69%
EBITDA Margin	-98.04%
EBIT Margin	-121.00%
FCF Margin	41.46%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.85%
Shareholder Yield	-58.85%
Earnings Yield	-35.69%
FCF Yield	19.81%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.73
Piotroski F-Score	n/a